# DAPAGLIFLOZIN

NDC: 69097-388
Generic name: DAPAGLIFLOZIN
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260406

FDA application: ANDA211535

## Active ingredients

- DAPAGLIFLOZIN PROPANEDIOL: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-388"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-388
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2f86c0a-ce78-4d06-b5d8-ed457c8e3614